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ABSTRACT 
Objective: At present opinions differ between American and European 
obstetricians regarding the necessity of routine screening obstetrical ultrasounds. 
Guidelines from the National Institutes ofHealth and the American College of 
Obstetricians and Gynecologists state that prenatal ultrasonography should be 
performed only when clinically indicated and not for screening purposes. Several 
studies that tested the proported benefits of routine screening examinations have 
yielded conflicting results. The current study was performed to examine 
reimbursement patterns by prenatal provider and insurance carrier, assess the 
quality of the University of North Carolina patient accounting system and from 
the data analysis suggest alternatives to increase the revenues collected. 
Methods: Data were collected from patients who received a diagnostic prenatal 
ultrasound at the University ofNorth Carolina Obstetrics and Gynecology 
Department during the month of October 2001. The patient population consisted 
of 1004 patients with various prenatal providers within the referral region. The 
ultrasounds were performed by experienced sonologists and Obstetricians using 
ATL HDI 5000 with 2.5 to 10 mHz transducers. Data were analyzed and 
configured using Microsoft Excel Spreadsheet and Microsoft Access Database 
2000. 
Results: The ultrasound charges ranged from $100 to $969. Out of the patient 
total the more frequently encountered forms of payment were Medicaid, Blue 
Cross Blue Shield, and self-paying. Outlying Clinics which consisted mostly of 
Medicaid recipients and self-paying patients had the least amount of allowable 
reimbursement, <37%. The University Obstetric Group, serving a large 
population of Blue Cross Blue Shield insurance carriers, received the highest 
amount of allowable reimbursements, 92%. Most of the prenatal care providers 
are receiving less than 60% of their allowable reimbursements for ultrasound 
services. 
Conclusions: No real pattern to reimbursements was obtained. The charges and 
reimbursements of the ultrasounds varied between the prenatal care providers and 
could even differ when one prenatal provider obtained an ultrasound on two 
patients for the same indication. Improvements in the current patient accounting 
system have to occur in order to obtain a pattern to reimbursement and properly 
track which patients are given a zero balance for reasons including Medicaid 
presumptive eligibility that failed and transfer of uncollected balances to the 
collections department. 
BACKGROUND 
Prenatal ultrasound examinations are obtained for both screening purposes 
and as a diagnostic tool. The indications for its use as a diagnostic procedure are 
extensive and are listed in Table 1. Screening or routine ultrasonography is 
conducted on women at low risk of pregnancy complications, that is, patients 
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without a clinical indication for a diagnostic ultrasound.1 While there is little 
question regarding the utility of diagnostic prenatal ultrasonography there is 
debate on its use as a routine screening examination.1•2 A retrospective study 
performed in the late 1970's showed that through earlier detection of twins, 
screening ultrasonography reduced the perinatal morbidity and mortality rate. 3 
However, several randomized controlled trials have shown conflicting results.4' 10 
Although some benefits such as early detection of a multiple gestation pregnancy 
detection are widely accepted, the degree of other proported benefits is 
controversial. In spite of the uncertainty that exists some countries employ 
ultrasonography as routine practice6 •11 The uncertainty within the medical 
community prompted the National Institutes of Health to sponsor a consensus 
conference in 1984 to assess the use of ultrasound imaging during pregnancy. 
The panel concluded that "the data on clinical efficacy and safety do not allow a 
recommendation for routine screening at this time". Therefore, prenatal 
ultrasound examination should only be obtained if medically indicated. 12 Within 
four years after the NIH panel, several professional societies including the 
American College of Obstetricians and Gynecology (ACOG) issued their first 
guidelines on the obstetrical ultrasound. 11 The American College of Obstetricians 
and Gynecologists held the same position as NIH on this issue and concluded that 
ultrasonography should be performed for specific indications rather than routine 
screening in low-risk pregnancies. 13•14 The US Preventive Services Task Force 
(USPSTF) assigns a Class "C" recommendation for routine screening 
examinations in low-risk patients because of the lack of sufficient scientific 
? 
evidence of its effectiveness. 13 The next few sections discuss the proported 
benefits of routine screening ultrasonography along with the data found in the 
literature. 
GESTATIONAL AGE 
Gestational age of the infant can be estimated from the last menstrual 
period (LMP), presence of quickening movements, tape measurements of fundal 
height, first heard fetal heart tones, and the date the uterus reaches the 
umbilicus. 15•16 Although gestational age can be approximated from the LMP, 
only 55% of women can report an optimal menstrual history. 15 The remaining 
women are considered to have uncertain histories due to poor recall ofLMP, 
irregularities in the menstrual cycle, oral contraceptive intake within two months 
of conception, and bleeding during early pregnancy. 15•17 Due to the lack of 
consistency in menstrual history recall, another method to adequately assess the 
gestational age of the infant is desirable. 
illtrasound scanning has been reported to give a more precise estimate of 
the gestational age. 18 Approximately 70% of prenatal ultrasounds performed are 
obtained to estimate gestational age. Campbell and colleagues conducted a study 
on 4527 pregnant women, comparing the ability of prenatal ultrasounds and 
menstrual history to predict gestational age. Optimal menstrual histories were 
reported by 55.3% of the patient population and of these, 84.7% delivered within 
two weeks of their estimated due date. Almost 9% of women were unsure of their 
LMP and of this group, 64.7% delivered within two weeks of their estimated date 
of confinement. Although there was no statistical difference between dating 
' 
' L 
I 
l 
t 
l 
obtained from the crown-rump length measurements and optimal menstrual 
histories, gestational age predicted by biparietal diameter (BPD) was statistically 
significant. The study found that BPD measurements obtained prior to 18 weeks' 
of gestation were better than optimal menstrual history and crown-rump length 
measurements at two-, three-, and four-week intervals. The investigators also 
found that between 18 and 28 weeks, the BPD was as equal a predictor of 
estimated date of confinement as an optimal menstrual history, but menstrual 
history was a much better predictor if the gestational age was beyond 28 weeks. 17 
A study performed in Malmo showed similar results to the study performed by 
Campbell et al. Of the 848 program participants with a BPD measurement at 17 
weeks' of gestation, 95% delivered within 12 days of their estimated date of 
confinement compared to 79.3% in the group that used the last menstrual period. 3 
Gardosi and Geirsson reported that estimated due dates based on the 
menstrual history systematically underestimate the prevalence of preterm births 
( <37 weeks gestational age) and at very early gestations tend to underestimate the 
fetal age compared to an early ultrasound scan. 19 Each year nearly 13 million 
preterm births occur worldwide. The importance of preventing preterm delivery 
has been demonstrated by numerous studies.20-22 Between 23 and 27 weeks of 
gestation, the fetal survival curve rises steeply at a rate of nearly 3% per day with 
an associated decrease in neonatal morbidity. 22 Thus even at early gestations, 
adequate assessment of gestational age can impact clinical management options 
and provide clues about the infant's chance of survival. The incidence of 
postdates pregnancy ranges from 2% to 12% when the LMP is used, but the 
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figures are lower when ultrasonographic dating is employed. 23 Postdates 
pregnancy is defined to extend beyond 42 weeks of gestation. It is possible that 
some women who undergo induction oflabor for suspected postdates pregnancy 
are within the preterm range. Since preterm birth is the major cause of morbidity 
and mortality in developed countries, it is paramount to find a technological 
advancement that would lead to a reduction in preterm births consequently 
decreasing the rate of infant deaths. 22 
CONGENITAL ANOMALIES & STRUCTURAL ABNORMALITIES 
It is believed that earlier detection of fetal anomalies or malformations 
will lead to an improvement in perinatal morbidity and mortality. In the U.S., 
congenital anomalies are the major cause of death before one year of age. 13 
Congenital anomalies occur in about two to four percent of all infants and are 
responsible for a quarter of all perinatal deaths. 15•24 Early detection of these 
anomalies would improve both management in the early neonatal and postpartum 
period25 Prenatal ultrasound examination can identify several fetal 
malformations. Ninety percent of cases occur in women with no known risk 
factors such as advanced maternal age, family history or previously affected 
pregnancy24 Structural defects identified via ultrasound examinations include 
abnormalities of the central nervous system, head, neck, cardiovascular system, 
chest, gastrointestinal tract, genitourinary tract and musculoskeletal system.25"31 
Early antenatal detection of fetal malformation is important both for 
women who may want a therapeutic abortion and to counsel those who want to 
continue their pregnancy about what to expect after delivery. 15 The sensitivity of 
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obstetric ultrasonography varies with the severity of the anomaly and can range 
from 39.4% to 83%24·32•33 One earlier study yielded a sensitivity of92% when 
ultrasound examination was performed 3 weeks prior to delivery. 18 A Belgian 
study conducted from 1984 to 1992 involved routine ultrasound examinations in 
over 26,000 pregnant women who were at normal risk for congenital anomalies. 
Of the 616 fetuses found to be structurally abnormal at birth or on autopsy of the 
aborted fetuses, 274 were detected via ultrasound giving an overall sensitivity of 
44.5% and specificity of99.9%. 32 
When early detection of major malformations leads to an elective 
termination nof pregnancy, it has led to a decrease in the perinatal mortality 
rate. 5'24 Goncalves and colleagues performed a study on 574 infants from a 
perinatal referral center. Cases were defined to be all single births or fetal deaths 
that had one or more detectable anomalies and where the mother had at least one 
ultrasonographic examination at or after 16 weeks of gestation. The study 
concluded that specificity was 99% and overall sensitivity for detecting any 
congenital anomaly was 53% with certain anomalies i.e. neural tube defects, renal 
agenesis and gastroschisis, having a 90% sensitivity. The detection oflethal 
anomalies had a sensitivity of 89% and infants requiring admission to the neonatal 
intensive care unit was 77%.26 Although this study produced interesting findings, 
it has weaknesses inherent to a case control study. The cases were obtained from 
hospital discharge diagnoses and it is possible that all cases may not have been 
captured if the ultrasound procedure did not detect the anomaly prior to delivery. 
The authors attempted to prevent this by identifying a priori the anomalies that 
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were considered undetectable by ultrasonography, but it still remains a possibility 
that an anomaly was missed. The study also lacked a reference population, 
therefore, lacking information on patients who had a false-negative ultrasound 
examination who sought care at another institution. 
A retrospective study ofultrasonographic findings and outcomes on 8733 
live infants and 52 aborted fetuses was done on a British population of women 
considered to be at low risk. Ninety-five percent of the ultrasound examinations 
were performed during the second trimester. Of the 130 fetuses born with an 
abnormality or found to have an abnormality on autopsy of the aborted fetuses, 
125 of them had been examined during the second trimester. In this study, 
prenatal ultrasounds obtained prior to 24 weeks of gestation had a sensitivity of 
74.4% with a 95% confidence interval of66.7% to 82.1% and a specificity of 
99.98%. Of the 125 abnormalities identified via the ultrasound, 87 were lethal or 
severely disabling. Ultrasound was able to detect 72 of the 87 severe cases24 It 
is thought that the high sensitivity of lethal anomaly detection will lead to induced 
abortions and consequently cause a decline in the perinatal mortality rate. 5•24 
INTRAUTERINE GROWTH RESTRICTION 
The estimated incidence of intrauterine growth restriction (IUGR) in the 
general population is five percent33 Fetuses that suffer IUGR are small for 
gestational age. Small for gestational age is defined to be a weight below the 
tenth percentile for age yet not all growth restricted fetuses have weights within 
this cutoff range. Usually if the etiologic process occurs during the first trimester 
the infant will have symmetric growth retardation, but if the insult occurs in the 
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third trimester the infant will suffer from asymmetric growth retardation. Risk 
factors for IUGR can be grouped into fetal, maternal, uterine, and placental 
factors. Maternal or fetal cardiac disease, smoking or alcohol intake during 
pregnancy, uteroplacental insufficiency, intrauterine infection, and placenta previa 
are examples of factors associated with fetal growth retardation33 
Studies have shown that perinatal morbidity and mortality in affected 
infants can be four to eight times greater than among unaffected fetuses. 34-36 
Because of the high risk of mortality and morbidity, it is imperative to identify 
affected fetuses early. Results of some studies show that infants removed from 
the inadequate enviromnent can have catch-up somatic and neurologic 
development by age two. 33 Intrauterine growth restriction beyond 36 weeks of 
gestation is an indication for delivery to reduce the risk of fetal death. 15 
Several parameters can be utilized to detect SGA fetuses. Clinical history, 
fundal height measurement, abdominal palpation, biochemical placental function 
tests, fetal fat assessment, anmiotic fluid volume and anmiotic fluid 
concentrations of phosphatidyl glycerol are examples of methods that can be 
used?7 The major problem with these various methods is that they miss a 
significant portion of women who have SGA fetuses. Only two thirds ofiUGR 
cases occur in women in the high risk group; therefore, one third of SGA cases 
would be missed if one relied on the presence of these risk factors. 15•33 Since 
abdominal palpation and measurement of fundal height are affected by the 
maternal body habitus, fetal lie, presence of uterine leiomyomas, and 
interobserver variability, these methods will also miss a significant portion of 
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affected fetuses. One study found that using fundal height measurements as a 
predictor ofiUGR had a sensitivity of64% and a positive predictive value of 
twenty-nine percent. 15 The use of biochemical markers such as estriols and 
human placental lactogen hormones, fetal fat assessment, and phosphatidyl 
glycerol concentrations are either insensitive, have a high false positive rate, or 
both.I5,37 
Measurements obtained from ultrasound examinations have proven to be 
superior to other methods in detecting SGA fetuses. 6•37-39 A two-stage ultrasound 
screening clinical study was conducted on 877 women with low risk pregnancies. 
The women had one ultrasound early in pregnancy to determine gestational age 
and then another one at 34 to 36 weeks of gestation. At the second examination I they were randomized to reported and non-reported groups with measurements of 
l 
the crown rump length (CRL) and trunk area (TA). The study results showed that 
the sensitivity and specificity for CRL x TA to detect SGA fetuses were 94% and 
90%, respectively. The sensitivities and specificities ofCRL and TA as individual 
units were lower than those of the combined measurements. 37 
Another study aimed at diagnosing SGA fetuses in a large general 
obstetric population was conducted on 3208 pregnant women in Finland The 
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women received one ultrasound screening examination at 18 weeks of gestation to 
confirm the gestational age and another one at 34 weeks to identify SGA fetuses. 
Each examination included measurements of the BPD and the transverse 
abdominal diameter. At a cutoff level of -1 standard deviation, the combined use 
Q 
ofBPD and transverse abdominal diameter detected 76.3% of SGA fetuses at 34 
weeks. The specificity was 84.8% and the positive predictive value was 20.4%39 
PERINATAL OUTCOMES 
The properties of a randomized controlled trial, the gold standard for 
assessing the efficacy of clinical interventions, enable it to control for 
confounding as an explanation to study findings. Several clinical trials have 
tested the hypothesis that routine ultrasonography reduces perinatal morbidity and 
mortality. 4-9 A study comparing the outcomes of a routinely screened group of 
2054 women versus 1358 women who had an indication for receiving an 
ultrasound showed that neonatal outcomes were similar between the two groups. 
However, 17.5% of women in the indicated ultrasound group had induction of 
labor compared to 13.9% in the routine group, and the difference is significant (p 
<0.05)7 Waldenstrom and colleagues performed a one stage screening clinical 
trial in Sweden on 7354 pregnant women. Women in the screening group received 
an ultrasound scan around 15 weeks of gestational age. Women in the unscreened 
group did not have an ultrasound prior to 19 weeks of gestational age. The study 
results showed no difference in the perinatal mortality rate between the two 
groups. However, low birthweight was significantly less common, 2.5% versus 
4.0%, in the screened group and mean birthweight was 42 grams more than in the 
unscreened group.4 Since the difference in birthweight between the two groups 
was among the women who reported smoking at their initial prenatal visit, it is 
believed that the women changed to a healthier life-style after viewing their fetus 
on the ultrasound monitor4 
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A Norwegian randomized trial performed by Bakketeig et a! involved 
1009 pregnant women who were randomly allocated to receive one ultrasound 
examination at the 19th and 32nd weeks of gestation, compared with no ultrasound 
screening. In the screened group there were fewer low birth weight infants (2.2% 
versus 3.6%) and slightly fewer post-term inductions (2.8% versus 4.0%) but the 
differences were not statistically significant.6 Another clinical study involving 
915 pregnant women was performed by Ewigman eta!. This study found no 
statistically significant difference between the experimental and control groups in 
adverse perinatal outcomes, 6. 7% versus 8.3%. There was also no statistically 
significant difference in labor inductions between the groups, 22.6% versus 
24.9%.8 However, the study may have been biased towards low risk pregnancies 
since the incidence of low birth weight babies in the study was lower than the 
background incidence. Therefore the results may not be generalizable to high-risk 
patients. 
The Helsinki Ultrasound Trial, a randomized trial performed in Finland, 
compared one stage ultrasonography screening with indicated use on 9310 
women. The screening group received ultrasound examinations between 16 to 20 
weeks gestational age, compared with follow-up only in the control group. The 
screened and unscreened groups had the same antenatal care and all women 
received an ultrasound if indicated according to usual practice. Although there 
were no statistical differences between the two groups based on mean birth 
weight, Apgar score at one minute, infants admitted to the neonatal intensive care 
units or length of hospital stay, there was a difference in mortality. This study 
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found a significant difference in the singleton perinatal mortality rate in the 
screening group compared with the control group, 4.2 versus 8.0 per 1000, 
respectively. 5 There were a couple of weaknesses in this study trial. The use of 
obstetric ultrasonography is so wide spread in Finland that only 25% of the 
control group had not received an examination during pregnancy. Also 25% of 
the screening group had already undergone ultrasonography before obtaining a 
screening ultrasound examination. 
The findings in the Helsinki trial contrast with the results obtained in the 
RADIUS study. The RADIUS (Routine Antenatal Diagnostic Imaging with 
illtrasound) trial, a multicenter randomized clinical trial performed in the United 
States involving 15,530 women is the largest clinical trial performed thus far. This 
study compared screening ultrasonography with indicated ultrasonography on the 
basis of clinical judgment in a low-risk population. The screened group had one 
sonogram examination performed at 18 to 20 weeks gestational age and the 
second one at 31 to 33 weeks. In addition to screening examinations, ultrasounds 
were also performed for medical indications in both the experimental and control 
groups. All women received the same antenatal care with the exception of the 
screening ultrasound. The study tested the hypothesis that screening 
ultrasonography would improve perinatal outcome and have a favorable impact 
on maternal management and outcome. The results found no clinically significant 
difference in perinatal morbidity and mortality or maternal management and 
outcome between the study groups. 9'10 The results of this study are not 
generalizable to all obstetric cases because the patients involved were low risk, 
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93% were Caucasian, and 95% were between the ages of20-35. Therefore, the r 
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results of this study may not be applicable to women who are a minority, older L 
than 35, or considered to be a high-risk case. 
When the benefits of a medical procedure are questionable should 
insurance companies cover the cost of the procedure or should it be the 
responsibility ofthe patient? This question prompted the current study focusing 
on data from obstetrical ultrasounds performed at the University ofNorth 
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Carolina Obstetrics and Gynecology (UNC Ob/Gyn) Department during the 
month of October 2001. The main objectives of the current study were 1) to 
analyze fmancial data to determine reimbursement patterns by various payers for 
i prenatal ultrasound examinations obtained at the UNC Ob/Gyn Department; and 2) to analyze reimbursement data by various UNC Ob/Gyn clinics. The goal is to 
improve tracking of patients' charges to increase revenue collected without 
decreasing access to care. 
METHODS 
Data were obtained from patients who visited and received a prenatal 
ultrasound at the University of North Carolina Obstetrics and Gynecology (UNC 
Ob/Gyn) clinics. The prenatal providers were the University Obstetric Group 
(UOG includes Maternal Fetal Medicine Faculty, Generalists, and Midwives), 
Obstetrics and Gynecology Resident physicians, UNC Family Medicine Clinic, 
Student Health Clinic, Outlying Clinics and Other clinics not included as part of 
the Outlying Clinics. The Outlying Clinics included six Health Departments 
located in Alamance County, Chatham City, Caswell City, Lee County, Orange 
County, and Randolph City. The remaining eleven constituents of Outlying 
Clinics include Caswell Family Medical Center, Tri City Community Health 
Center, Carrboro Piedmont Health Services (PHS), Haywood Moncure PHS, 
Prospect Hill PHS, Charles Drew Clinic PHS, Siler City Community Health 
Center, Piedmont Womens Health Birthing Center, Anderson Creek Medical 
Center, and Boone Trail Medical Center. The chosen time period was October 1, 
2001 through October 31, 2001. All women who entered the clinic during this 
time period and received a diagnostic prenatal ultrasound were eligible for the 
study. The variables collected included medical record numbers, CPT codes, 
prenatal provider, date of ultrasound, gestational age at ultrasound obtaimnent, 
dates of any previous ultrasounds during the stated month, and indication for 
obtaining the ultrasound. The indications for obtaining an ultrasound were 
advanced maternal age, vaginal bleeding during pregnancy, fetal monitoring, 
genetic evaluations, growth discrepancies, maternal medical illness/conditions, 
multiple gestations, uncertain gestational age (GA), and other reasons. Forty-five 
patients did not have any reason specified. The study included 1004 patients eight 
of whom did not have a prenatal provider listed. These patients were included in 
the study analysis. Data were analyzed using Microsoft Excel Spreadsheet and 
Microsoft Access Database 2000. 
The ultrasound examinations were performed by experienced sonologists 
and Obstetricians using ATL HDI 5000 with 2.5 to 10 mHz transducers. All 
sonologists graduated from an accredited ultrasound program and have current 
registration with the Association of Registered Diagnostic Medical Sonographers. 
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RESULTS 
There were several reasons why patients obtained ultrasounds (Figure 1 ). 
The majority of patients were seen for discrepancies between the size of the 
uterus and the estimated gestational age, fetal monitoring, uncertain gestational 
age, and other reasons not included as the main categories. Approximately 4.5% 
of patients did not have any reason listed for receiving an ultrasound. The least 
common reason for having an ultrasound was for vaginal bleeding during 
pregnancy (1.0%). 
The breakdown of insurance type by prenatal provider is listed in Table 2. 
Most of the patients seen by the University Obstetric Group, UNC Family 
Medicine Clinic, and Student Health had Blue Cross Blue Shield insurance. The 
majority of patients seen by Resident Physicians and the Other category (patients 
who were not seen by the listed groups) were Medicaid recipients. Most patients 
who attended the Outlying Clinics were self-paying. Out of the patient total the 
more frequently encountered forms of payment were Medicaid, Blue Cross Blue 
Shield, and self-paying. Table 3 lists the prenatal providers and the percentages 
of various insurance types that the patients carried. 
The amount UNC charged for the ultrasounds ranged from $100 to $969. 
The higher end of the range was for growth discrepancies, multiple gestations, 
and fetal monitoring. Table 4 provides a listing of the sum of original charge 
amounts, adjusted amounts, amount collected and the average collected percents 
according to prenatal provider. The adjusted amount column is the sum of the 
reduced charges based on the contractual agreement with the various insurance 
types. The average original collected percent was obtained prior to summation of 
the charges and is based on the amount received and the original charge amount. 
The average adjusted amount is based on the figures within the table and is 
calculated from the amount received and the adjusted amount after the contractual 
agreement. The majority of prenatal providers are collecting less than 60% of 
their fees for providing ultrasound services to their patients. The DOG and 
Faculty group received the highest amount of reimbursement after adjustments 
and the outlying clinics received the least amount. 
The sum of original charges, adjusted charges, amount received, and 
average collected percents according to insurance type are in Table 5. The 
average original and adjusted collected percents were obtained by the same I calculations as Table 4. None of the prenatal clinics received 100% 
reimbursements for ultrasound services when observing the average percent 
collected based on original and adjusted amount columns. Medicaid carriers had 
the highest amount of charges in both the original and adjusted columns yet the 
reimbursement was less than 35 percent. The second highest insurance carrier 
was Blue Cross Blue Shield with a reimbursement rate of 65% after contractual 
agreement. The self-paying group had the least amount of reimbursement. 
DISCUSSION 
The advent of managed care has altered the course of medicine. Physicians 
are being reimbursed less for services rendered causing physicians to find other 
methods of maximizing their reimbursements. The data show that DOG had the 
highest reimbursement and Outlying Clinics had the least amount. On further 
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analysis the data also show that UOG had a large portion of Blue Cross Blue ! 
Shield insurance carriers, which had one of the higher reimbursement amount l 
among the insurance types. A large portion of the Outlying Clinics patients were 
Medicaid carriers, which has one of the lower reimbursement rates among the 
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vanous msurance earners. 
It is not possible to state that a particular prenatal provider charged a 
certain amount for an ultrasound for a given reason. Some patients were charged 
different amounts even when they had the same prenatal provider and reason for 
obtaining an ultrasound. For example, a patient who was seen by UOG had an 
original charge of $646 for an ultrasound received for evaluation of multiple 
I gestations and another patient was charged $139. The patient who was charged more was 17 weeks of gestational age and the other patient was 29 weeks. Both 
patients had received a previous ultrasound that month. Possible explanations for 
the higher charge include that 1) the patient with the higher charge had more than 
one reason for receiving an ultrasound but only one was listed; 2) she was a 
higher risk patient; 3) she had a different insurance carrier; 4) an error was made 
in charge amount; 5) there was some other reason. The majority of insurance 
companies pay a differential rate for first time versus repeat ultrasonography 
regardless of the components of the examination. The insurance companies pay 
more for the initial scan and in some cases, the differential in the fees can be as 
much as $50040 Some of the patients in this study received more than one 
ultrasonographic examination during the month that the data were obtained. 
Although not an objective of the current study, completion of this research may 
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require this information to evaluate the number of ultrasound procedures received 
and the reimbursement rate or pattern for repeat examinations. 
It is generally accepted that ultrasonography is a safe procedure, but it 
should only be performed for a valid medical reason at the lowest setting possible 
to obtain necessary information. Infants who were exposed to ultrasounds in 
utero have not been shown to have different birth size, child growth, cognitive 
function, or neurological capabilities from those who were not exposed. Although 
the US Food and Drug Administration defmes a safe level of ultrasound exposure 
to be less than 94 mW/cm2, diagnostic ultrasonographic examinations have 
energies less than 20 m W/cm241 The employment of energies well below the 
standard value ensures the safe use of this procedure for routine or diagnostic 
purposes. 
The cost of an ultrasound depends on the time required to complete the 
examination, equipment cost, experience of the person performing the 
examination, and insurance cost. 15 The cost of screening ultrasonography is 
approximately $20042 Prior to cost adjustments based on insurance contractual 
agreements, most prenatal providers received less than 50% of reimbursements 
for ultrasound services. When adjustments were taken into consideration, one 
prenatal provider received greater than 100% of their reimbursements. The 
inability to collect 100% of reimbursement for ultrasound services even after 
contractual agreement may be secondary to the patient not being able to pay their 
portion of the charges or a defect in the tracking of the patient accounting system, 
but this warrants further investigation and scrutiny of the data. Although patients 
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with Doctors, Alliance, and Healthsource insurance types had the highest percent 
of total charges collected after adjustment, they represent only 2.3% ofthe patient 
population. Medicaid patients accounted for 32.7% of the patient population yet 
UNC collected only 34% of total charges after adjusting. Similarly, the self-
paying group represented 14.5%, but only 27% of charges were collected. 
The information obtained from this research has the potential to affect 
policies governing obstetrical ultrasounds performed at UNC. In the late 1980's 
a series of bills passed designed to reduce the US infant mortality rate, mandated 
health insurance coverage through the Medicaid program for all poor pregnant 
and postpartum women and their infants43 The Medicaid program permits 
women who are awaiting approval of their Medicaid to be classified as 
presumptive eligibility. Presumptive eligibility allows the women to obtain 
prenatal care services without payment for services received until their Medicaid 
has been approved. In this study Medicaid and the self-paying group had the 
lowest reimbursements. Shonld Obstetrical Clinics limit the number of patient 
enrollments with these modes of payments or should the number of ultrasounds 
they obtain be limited? Should there be restrictions on the number of patients 
accepted with presumptive eligibility status? Is it ethical for academic medical 
centers to limit the amount of services provided based on insurance carrier and 
reimbursement potential? What happens to the Prenatal Providers where 
Medicaid insurance dominates, for example in the Outlying Clinics. In reality 
deciding to accept a limited number of patients may be an option for the private 
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sector, but not for academic medical centers and health departments who serve a 
disproportionate amount of poorly insured and uninsured patients. 44 . r 
The net amount of money that UNC loses in obstetrical ultrasounds may 
be a reflection of the quality of the current patient tracking system. In the current 
system, when a charge has not been paid for a couple of months, it is sent to the 
collections department and automatically assigned a zero balance. 
Reimbursements could be increased if the current tracking system did not assign a 
zero balance to claims that have not been paid or at least prolong the time that is 
required for assignment of a zero balance. The system can also be improved by 
maintaining a record of the patients classified as presumptive eligibility and who 
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were subsequently denied Medicaid. Were these services also written off as a 
zero balance? It appears that there is not a way of tracking this information with 
the current system. Modifying the current patient accounting system may be the 
optimal method to impact on the system to increase revenues collected without 
decreasing access to care. 
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Table 1. Indications for ultrasonographic examinations (adapted from 1,2) 
Abnormal amniotic fluid volume 
Abnormal maternal serum biochemical markers (MSAFP or triple screen) 
Adjunct to amniocentesis 
Adjunct to cervical cerclage placement 
Adjunct to external version from breech to vertex presentation 
Advanced maternal age 
Biophysical evaluation of fetal well-being 
Determination offetal presentation 
Estimation of fetal weight and/or presentation in premature rupture of membranes and/or 
premature labor 
Estimation of gestational age uncertain clinical dates, or verification of dates for scheduled 
elective 
Cesarean section, indicated induction oflabor, or elective termination of pregnancy 
Evaluation of fetal condition in late presentation to prenatal care 
Evaluation offetal growth 
Family history of congenital anomalies 
Follow-up observation evaluation of placental localization for identified placenta previa 
Follow-up observation ofidentified fetal anomaly or known chromosomal aberration 
Intrauterine contraceptive device localization 
Isoimmunization with antibodies known to cause hydrops fetalis 
Maternal medical illnesses associated with increased risk of congenital anomalies 
Observation of intrapartum events 
Pelvic mass 
Previous infant with congenital anomaly 
Serial evaluation offetal growth in multiple gestation 
Suspected abruptio placenta 
Suspected hydatidiform mole 
Suspected intrauterine fetal demise 
Suspected multiple gestation 
Suspected uterine anomaly 
Teratogen exposure during organogenesis 
Uterine size/clinical dates discrepancy 
Vaginal bleeding 
Figure 1 
Reason for Ultrasound 
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* S and D stand for size of uterus and dates of gestation. 
**GA represents gestational age 
Table 2. The number of patients seen by the prenatal provider and their insurance 
earner. 
Table 3. Percentage of patients carrying a particular insurance type grouped by 
prenatal provider 
?? 
t 
~-
l 
I 
Table 4. Percent of original charge amount collected according to prenatal 
provider 
--- --- - ---- --- ---------
235 $41,601.00 $21,331.10 $19,623.90 
---- ---- ----
----- ----------- ·-------
Resident 265 $39,523.00 $28,230.61 $11,292.39 
Outlying Clinics 156 $25,228.00 $18,536.67 $6,691.33 
UNC Family Med. 28 $4,840.00 $3, 115.23' $1 '724. 77 
Student Health 6 $902.00 $618.66 $283.34 
Other 306 $49,415.00 $32,062.99 $16,849.41 
*Approximation calculated from the received and amount 
* • Approximation calculated from the received and adjusted amount column after summation 
j 
l 
.L 
I 
! 
I 
• 
Table 5. Percent of original charge amount collected according to insurance 
earner. 
amount 
**Approximation calculated from the received and adjusted amount column after summation 
I 
?4 
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